IRIS
BARBARACI, CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 695
NA - Nord America 25
AF - Africa 9
AS - Asia 8
OC - Oceania 8
Totale 745
Salva come PNG Salva come JPEG
Nazione #
FR - Francia 650
IT - Italia 31
US - Stati Uniti d'America 15
CA - Canada 10
CI - Costa d'Avorio 9
AU - Australia 8
RU - Federazione Russa 7
DE - Germania 5
VN - Vietnam 4
ID - Indonesia 2
IE - Irlanda 2
JP - Giappone 1
TW - Taiwan 1
Totale 745
Salva come PNG Salva come JPEG
Città #
Paris 74
Catania 27
Halifax 10
Abidjan 9
Columbus 7
Hobart 7
Dong Ket 3
Frankfurt am Main 3
Banjarmasin 2
Boardman 2
Dublin 2
Milan 2
St Petersburg 2
Voronezh 2
Bremen 1
Council Bluffs 1
Gatchina 1
Hanoi 1
Moscow 1
New York 1
Perm 1
San Jose 1
Shiga 1
Sydney 1
Taipei City 1
Vittoria 1
Totale 164
Salva come PNG Salva come JPEG
Nome #
Ligandi ibridi Sigma-HDAC come potenziale trattamento terapeutico per il melanoma uveale: design, sintesi e valutazione biologica, file 82995783-2000-4605-a06a-e58f06773934 663
A structure-and ligand-based virtual screening of a database of “small” marine natural products for the identification of “blue” sigma-2 receptor ligands, file dfe4d22c-f857-bb0a-e053-d805fe0a78d9 35
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma, file dfe4d22e-52b1-bb0a-e053-d805fe0a78d9 12
Nanostructured lipid carrier for the ophthalmic delivery of haloperidol metabolite II valproate ester (±)-MRJF22: A potential strategy in the treatment of uveal melanoma, file 7b4005c3-ad5c-4ee1-a5aa-ea24ec979e9c 6
Interaction of new sigma ligands with biomembrane models evaluated by differential scanning calorimetry and Langmuir-Blodgett studies, file dfe4d22e-a07e-bb0a-e053-d805fe0a78d9 4
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity, file f9f8dca3-6ec7-4221-9c41-4760b5c358e4 4
Preliminary in vitro and in vivo studies of (S)-(–)-MRJF22 loaded-NLC for potential treatment of uveal melanoma, file 6b2006fc-bf58-4b5e-9092-a182b3f0a424 3
Design, synthesis, and pharmacological evaluation of NO donor-sigma receptors hybrids for the treatment of cancer, file dfe4d229-0a61-bb0a-e053-d805fe0a78d9 3
Synthesis of “no-light activated” Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents, file dfe4d229-8dce-bb0a-e053-d805fe0a78d9 3
Development of novel H2S-donor sigma receptor hybrids for the management of pain., file dfe4d229-cad6-bb0a-e053-d805fe0a78d9 3
NLC for the delivery of new prodrugs in the treatment of uveal melanoma, file 69481d49-69f2-4265-92ca-3e179dc4fa6f 2
NLC as promising platform to deliver new prodrugs in the treatment of ophthalmic cancer, file d5a80cb4-95aa-4ac6-8138-18975cc99ccf 2
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders, file dfe4d229-75b3-bb0a-e053-d805fe0a78d9 2
Design, Synthesis and biological evaluation of hybrid MOR agonist/ HDACi molecules as potential therapeutic agents for chronic pain treatment, file 131a87c9-ac21-477e-a7cf-a2e8fc0282fa 1
Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands, file 61713f9d-aa40-4ca6-9f1a-63a80ea247ea 1
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation, file dfe4d22e-c01c-bb0a-e053-d805fe0a78d9 1
Totale 745
Salva come PNG Salva come JPEG
Categoria #
all - tutte 896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 4 0 0 0 0 0 0 0 0 0 0 3
2021/20222 0 1 0 0 0 0 0 1 0 0 0 0
2022/202323 0 0 0 4 1 1 4 0 2 2 9 0
2023/2024712 0 4 0 7 1 369 82 223 15 4 7 0
Totale 745